0001209191-20-054686.txt : 20201013
0001209191-20-054686.hdr.sgml : 20201013
20201013172250
ACCESSION NUMBER: 0001209191-20-054686
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20201013
FILED AS OF DATE: 20201013
DATE AS OF CHANGE: 20201013
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PARMAR KUSH
CENTRAL INDEX KEY: 0001664281
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39612
FILM NUMBER: 201237410
MAIL ADDRESS:
STREET 1: C/O AUDENTES THERAPEUTICS, INC.
STREET 2: 101 MONTGOMERY ST., SUITE 2650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 5:01 Acquisition Corp.
CENTRAL INDEX KEY: 0001823465
STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770]
IRS NUMBER: 852790755
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 501 SECOND STREET, SUITE 350
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
BUSINESS PHONE: 415-993-8570
MAIL ADDRESS:
STREET 1: 501 SECOND STREET, SUITE 350
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2020-10-13
0
0001823465
5:01 Acquisition Corp.
FVAM
0001664281
PARMAR KUSH
C/O 5:01 ACQUISITION CORP.
501 SECOND STREET, SUITE 350
SAN FRANCISCO
CA
94107
1
1
1
0
Co-CEO
Class B Common Stock
0.00
Class A Common Stock
2300000
I
See Footnote
As described in the issuer's registration statement on Form S-1 (File No. 333-249036) under the heading "Description of Securities - Founder Shares and Private Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination or earlier at the option of the holder, on a one-for-one basis, subject to adjustment for stock splits, stock capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights and have no expiration date.
The shares of Class B common stock owned by the Reporting Person includes up to 300,000 shares that are subject to forfeiture in the event the underwriters of the initial public offering of the issuer's securities do not exercise in full their over-allotment option as described in the issuer's registration statement.
Consists of shares held by 5:01 Acquisition, LLC ("Acquisition LLC") of which the Reporting Person is a manager. As such, the Reporting Person has voting and investment discretion and may be deemed to have beneficial ownership with respect to the shares of Class B Common Stock held by Acquisition LLC. The Reporting Person disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
Exhibit 24 - Exhibit List - Power of Attorney
/s/ Marianne Sarrazin, as Attorney-in-Fact
2020-10-13
EX-24.3_941338
2
poa.txt
POA DOCUMENT
AUTHORIZATION LETTER
October 13, 2020
Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Attn: Filing Desk
To Whom It May Concern:
By means of this letter I authorize Galya Blachman, Ph.D., Esq., Rebecca Lucia,
CFA, Nicole Brookshire, Al Browne, Marianne Sarrazin and Nathan Jefferies, or
any of them individually, to sign on my behalf all forms required under Section
16(a) of the Securities Exchange Act of 1934, as amended, relating to
transactions involving the stock or derivative securities of 5:01 Acquisition
Corp., the Company. Any of these individuals is accordingly authorized to sign
any Form 3, Form 4, Form 5 or amendment thereto that I am required to file with
the same effect as if I had signed them myself.
This authorization shall remain in effect until revoked in writing by me.
Yours truly,
/s/ Kush M. Parmar
LIMITED POWER OF ATTORNEY FOR SECTION 16(a) FILINGS
Know all by these presents, that the undersigned hereby constitutes and appoints
Galya Blachman, Ph.D., Esq., Rebecca Lucia, CFA, Nicole Brookshire, Al Browne,
Marianne Sarrazin and Nathan Jefferies, signing individually, as the
undersigneds true and lawful attorney-in-fact to:
(1) Execute for and on behalf of the undersigned, in the undersigneds capacity
as an officer, director and/or stockholder of 5:01 Acquisition Corp., the
Company, Forms 3, 4, and 5 and amendments thereto in accordance with Section
16(a) of the Securities Exchange Act of 1934, as amended, the Exchange Act, and
the rules thereunder;
(2) Do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3, 4, or 5
or amendment thereto and timely file such form with the United States Securities
and Exchange Commission, the SEC, and any stock exchange or similar authority;
and
(3) Take any other action of any type whatsoever which, in the opinion of any
such attorney-in-fact, may be necessary or desirable in connection with the
foregoing authority, it being understood that the documents executed by and such
attorney-in-fact on behalf of the undersigned pursuant to this Limited Power of
Attorney shall be in such form and shall contain such terms and conditions as
such attorney-in-fact may approve in such attorney-in-facts discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever required,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-facts substitute or substitutes, shall lawfully do or cause to be
done by virtue of this Limited Power of Attorney and the rights and powers
herein granted. The undersigned acknowledges that each of the foregoing
attorney-in-facts, in serving in such capacity at the request of the
undersigned, is not assuming, nor is any Company assuming, any of the
undersigneds responsibilities to comply with Section 16 of the Exchange Act.
This Limited Power of Attorney shall remain in full force and effect until the
earlier to occur of (a) undersigned is no longer required to file Forms 3, 4,
and 5 with respect to any securities issued by the Company, (b) revocation by
the undersigned in a signed writing delivered to the foregoing attorney-in-fact
and (c) as to any attorney-in-fact individually, until such attorney-in-fact is
no longer employed by the Company. This Limited Power of Attorney may be filed
with the SEC as a confirming statement of the authority granted herein.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of October 13, 2020.
/s/ Kush M. Parmar